Total Payments
$4,044
2024 Payments
$736.25
Companies
35
Transactions
193
Medicare Patients
4,415
Medicare Billing
$756,567
Payment Breakdown by Category
Food & Beverage$3,882 (96.0%)
Education$161.98 (4.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,882 | 191 | 96.0% |
| Education | $161.98 | 2 | 4.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $399.13 | 16 | $0 (2019) |
| OPKO Pharmaceuticals, LLC | $381.70 | 20 | $0 (2024) |
| NxStage Medical, Inc. | $320.07 | 4 | $0 (2022) |
| Relypsa, Inc. | $309.44 | 24 | $0 (2020) |
| AKEBIA THERAPEUTICS INC | $219.87 | 11 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $186.79 | 11 | $0 (2024) |
| Amgen Inc. | $183.62 | 8 | $0 (2024) |
| CALLIDITAS THERAPEUTICS US INC. | $160.94 | 8 | $0 (2024) |
| Medtronic, Inc. | $156.55 | 1 | $0 (2021) |
| Novo Nordisk Inc | $145.35 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $736.25 | 38 | CALLIDITAS THERAPEUTICS US INC. ($108.77) |
| 2023 | $522.50 | 26 | OPKO Pharmaceuticals, LLC ($87.01) |
| 2022 | $212.53 | 4 | NxStage Medical, Inc. ($124.99) |
| 2021 | $641.37 | 20 | NxStage Medical, Inc. ($195.08) |
| 2020 | $265.88 | 13 | OPKO Pharmaceuticals, LLC ($45.27) |
| 2019 | $468.96 | 25 | AKEBIA THERAPEUTICS INC ($94.93) |
| 2018 | $657.87 | 35 | Mallinckrodt LLC ($227.70) |
| 2017 | $538.89 | 32 | Mallinckrodt LLC ($116.72) |
All Payment Transactions
193 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $27.03 | General |
| Category: Inflammation | ||||||
| 10/23/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Nephrology | ||||||
| 10/10/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/07/2024 | Novo Nordisk Inc | Rivfloza (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Rare Disease | ||||||
| 10/03/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: NEPHROLOGY | ||||||
| 09/24/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $16.84 | General |
| 09/11/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: NEPHROLOGY | ||||||
| 09/10/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Hyperkalemia | ||||||
| 09/05/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/04/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: NEPHROLOGY | ||||||
| 08/30/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $33.42 | General |
| Category: Immunology | ||||||
| 08/26/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Hyperkalemia | ||||||
| 08/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: DIABETES | ||||||
| 07/31/2024 | Fresenius USA Marketing, Inc. | LIBERTY SELECT CYCLER (Device), NXSTAGE SYSTEM ONE | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Nephrology | ||||||
| 07/30/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: Nephrology | ||||||
| 07/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Cardio-renal | ||||||
| 06/14/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/15/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $19.54 | General |
| 05/15/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $2.72 | General |
| 04/18/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Nephrology | ||||||
| 04/17/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 04/16/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $20.87 | General |
| 04/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 802 | 4,172 | $369,779 | $140,995 |
| 2022 | 14 | 983 | 1,595 | $346,303 | $140,111 |
| 2021 | 17 | 1,390 | 2,265 | $551,381 | $248,011 |
| 2020 | 16 | 1,240 | 2,332 | $499,825 | $227,450 |
Total Patients
4,415
Total Services
10,364
Medicare Billing
$756,567
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 32 | 92 | $55,200 | $25,645 | 46.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 170 | 403 | $48,360 | $24,111 | 49.9% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 14 | 75 | $36,000 | $17,227 | 47.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 142 | 233 | $65,715 | $16,078 | 24.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 92 | 97 | $32,495 | $13,011 | 40.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 44 | 72 | $12,555 | $6,554 | 52.2% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 14 | 28 | $13,580 | $6,301 | 46.4% |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 2023 | 11 | 2,800 | $33,600 | $5,943 | 17.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 59 | 66 | $12,870 | $4,875 | 37.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 39 | 39 | $9,360 | $3,824 | 40.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 32 | 37 | $10,693 | $3,761 | 35.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $5,920 | $2,709 | 45.8% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 31 | 45 | $6,975 | $2,470 | 35.4% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2023 | 11 | 35 | $5,775 | $2,153 | 37.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 19 | 19 | $5,095 | $1,601 | 31.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 27 | $7,290 | $1,516 | 20.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 16 | 16 | $3,360 | $1,415 | 42.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,190 | $1,410 | 44.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 34 | $1,530 | $336.00 | 22.0% |
| 85018 | Blood count, hemoglobin | Office | 2023 | 13 | 27 | $216.00 | $55.68 | 25.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 264 | 635 | $76,200 | $34,814 | 45.7% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 32 | 73 | $43,800 | $20,422 | 46.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 109 | 114 | $38,190 | $17,240 | 45.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 163 | 242 | $69,068 | $16,377 | 23.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 94 | 119 | $23,205 | $10,742 | 46.3% |
About Dr. Ryan Lustig, M.D
Dr. Ryan Lustig, M.D is a Nephrology healthcare provider based in Kansas City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1124246335.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Lustig, M.D has received a total of $4,044 in payments from pharmaceutical and medical device companies, with $736.25 received in 2024. These payments were reported across 193 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($3,882).
As a Medicare-enrolled provider, Lustig has provided services to 4,415 Medicare beneficiaries, totaling 10,364 services with total Medicare billing of $756,567. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Internal Medicine, Nephrology
- Location Kansas City, MO
- Active Since 04/23/2007
- Last Updated 12/12/2012
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1124246335
Products in Payments
- ACTHAR (Biological) $522.78
- Veltassa (Drug) $361.98
- NXSTAGE SYSTEM ONE (Device) $320.07
- Auryxia (Drug) $221.15
- RAYALDEE (Drug) $205.91
- Rayaldee (Drug) $175.79
- TARPEYO (Drug) $160.94
- Kerendia (Drug) $144.51
- AURYXIA (Drug) $135.85
- LOKELMA (Drug) $115.24
- INJECTAFER (Drug) $115.07
- JYNARQUE (Drug) $92.92
- PURIFIED CORTROPHIN GEL (Drug) $86.82
- GALAFOLD (Drug) $77.78
- Parsabiv (Biological) $64.06
- Rybelsus (Drug) $62.28
- Velphoro (Drug) $60.16
- ENTRESTO (Drug) $56.37
- FABRAZYME (Biological) $47.24
- Rivfloza (Drug) $43.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Kansas City
Ahmed Awad, Do, DO
Nephrology — Payments: $186,893
Nephrology $186,893
Dr. Richard Capling, D.o, D.O
Nephrology — Payments: $46,864
Nephrology $46,864
Dr. Tarek Darwish, Md, MD
Nephrology — Payments: $17,350
Nephrology $17,350
Aditi Gupta, M.d, M.D
Nephrology — Payments: $16,492
Nephrology $16,492
Dr. Alan Yu, M.b.,B.chir, M.B.,B.CHIR
Nephrology — Payments: $14,413
Nephrology $14,413
Ahmad Tuffaha, M.d, M.D
Nephrology — Payments: $12,646
Nephrology $12,646